| DM (n = 20) | non-DM (n = 20) | p value |
---|---|---|---|
Age (years) | 64.2 ± 12.1 | 66.6 ± 15.9 | 0.593 |
Gender, male (%) | 15 (75) | 12 (60) | 0.311 |
STEMI, n (%) | 8 (40) | 16 (80) | 0.010 |
NSTEMI, n (%) | 5 (25) | 1 (5) | 0.091 |
UAP, n (%) | 7 (35) | 3 (15) | 0.137 |
Risk factor | |||
 Hypertension, n (%) | 13 (65) | 10 (50) | 0.337 |
 Dyslipidemia, n (%) | 10 (50) | 12 (60) | 0.525 |
 Hyperuremia, n (%) | 4 (20) | 1 (5) | 0.342 |
 Obesity, n (%) | 8 (40) | 4 (20) | 0.168 |
 Smoker, n (%) | 11 (55) | 8 (40) | 0.342 |
 Family history, n (%) | 4 (20) | 2 (10) | 0.661 |
Medication | |||
 Aspirin, n (%) | 4 (20) | 1 (5) | 0.342 |
 Calcium channel blocker, n (%) | 6 (30) | 7 (35) | 0.736 |
 ACEI/ARB, n (%) | 9 (45) | 4 (20) | 0.091 |
 Beta blocker, n (%) | 4 (20) | 0 (0) | 0.106 |
 Diuretics, n (%) | 1 (5) | 1 (5) | 1.000 |
 Statin, n (%) | 5 (25) | 3 (15) | 0.695 |
 Antidiabetic drug, n (%) | 11 (55) | 0 (0) | < 0.0001 |
  Sulfonylurea, n (%) | 4 (20) | 0 (0) | 0.106 |
  DPP-4 inhibitor, n (%) | 8 (40) | 0 (0) | 0.003 |
  Insulin, n (%) | 1 (5) | 0 (0) | < 0.0001 |
Laboratory findings | |||
 Hemoglobin (g/dl) | 13.3 ± 2.2 | 13.0 ± 2.4 | 0.751 |
 Creatinine (mg/dl) | 0.93 ± 0.45 | 0.75 ± 0.16 | 0.116 |
 BUN (mg/dl) | 19.0 ± 11.7 | 14.1 ± 4.4 | 0.091 |
 eGFR (ml/min/1.73 m2) | 68.7 ± 23.6 | 76.6 ± 23.2 | 0.296 |
 Total-C (mg/dl) | 206.0 ± 50.7 | 206.8 ± 42.0 | 0.957 |
 HDL-C (mg/dl) | 39.8 ± 8.1 | 45.1 ± 13.7 | 0.157 |
 LDL-C (mg/dl) | 131.1 ± 44.8 | 132.5 ± 33.3 | 0.916 |
 TG (mg/dl) | 173.6 ± 119.9 | 111.1 ± 70.7 | 0.058 |
 HbA1c(NGSP) (%) | 8.0 ± 2.4 | 5.7 ± 0.2 | 0.001 |
 UA (mg/dl) | 5.8 ± 1.8 | 5.5 ± 1.5 | 0.550 |
 hsCRP (mg/dl) | 0.21 ± 0.15 | 0.21 ± 0.37 | 1.000 |